August 28, 2014Open Access
Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis
Key Points
Key points are not available for this paper at this time.
Abstract
Serum concentrations of infliximab are associated with efficacy in patients with moderate-to-severe ulcerative colitis; however, complex factors determine the relationship between exposure to this drug and response. A prospective evaluation of the value of measuring serum concentrations of infliximab should be performed before these data can be included in patient management strategies. Clinicaltrials.gov numbers: NCT00036439 and NCT00096655.